Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Ratio of women stricken with MS rockets by 50% each decade

According to a study in the United States although women have always had a greater susceptibility for developing Multiple Sclerosis (MS) than men, the numbers have rocketed in the last six decades.

29 Apr 2007

More women developing multiple sclerosis than men

Over time, more women are developing multiple sclerosis (MS) than men, according to research that will be presented at the American Academy of Neurology's 59th Annual Meeting in Boston, April 28 - May 5, 2007.

27 Apr 2007

BioMS Medical announces lead investigator in phase III multiple sclerosis trial

BioMS Medical Corp has announced Dr. Clyde E. Markowitz as the lead investigator in the United States for the Company's pivotal phase III clinical trial of its lead drug, MBP8298, for the treatment of secondary progressive multiple sclerosis.

24 Apr 2007

Burnham awarded $7.39 million for study on Neuron-Glia communication in development

A team of researchers at the Burnham Institute for Medical Research (“Burnham”) has been awarded $7.39 million from the National Institute of Child Health and Human Development of the National Institutes of Health.

24 Apr 2007

New understanding of schizophrenia

New research helps bridge an important gap in understanding schizophrenia, providing the best evidence to date that defects in the brain's white matter are a key contributor to the disease, which affects about 1 percent of people worldwide.

24 Apr 2007

Pediatric multiple sclerosis and related disorders

Pediatric Multiple Sclerosis and Related Disorders has just been published by the International Pediatric MS Study Group as a supplement to the journal Neurology.

24 Apr 2007

Potential therapeutic target for multiple sclerosis

Oregon Health & Science University neuroscientists are eyeing a protein as a potential therapeutic target for multiple sclerosis because de-activating it protects nerve fibers from damage.

24 Apr 2007

New combined imaging promises insights into multiple sclerosis

Researchers have developed a way to use three types of microscopic imaging techniques simultaneously to analyze living tissue and learn more about the molecular mechanisms of multiple sclerosis, information that could help lead to earlier detection and new treatments.

18 Apr 2007

Single master gene crucial for nerve cell insulation

Researchers funded by the National Institutes of Health have discovered how a defect in a single master gene disrupts the process by which several genes interact to create myelin, a fatty coating that covers nerve cells and increases the speed and reliability of their electrical signals.

17 Apr 2007

Effective noninvasive treatment option for trigeminal neuralgia-related pain

Trigeminal neuralgia or tic douloureux is sometimes described as the most excruciating pain known to humanity.

17 Apr 2007

Natalizumab (Tysabri) reduces vision loss in MS patients

According to a study that appears in the April 17 issue of Neurology, researchers at the University of Pennsylvania School of Medicine have found that natalizumab (TYSABRI), a drug that slows disability and reduces relapse rates in patients with multiple sclerosis (MS), also reduces vision loss in patients with relapsing MS.

17 Apr 2007

Osprey Pharmaceuticals issued 3 U.S. patents

Osprey Pharmaceuticals Limited has announced that it has been granted three patents by the U.S. Patent Office.

17 Apr 2007

MS patients not receiving medications to slow disease progression

Neurologists at Wake Forest University Baptist Medical Center have found that many patients diagnosed with multiple sclerosis (MS) are not taking or being prescribed drugs approved to treat the disease.

17 Apr 2007

Natalizumab helps reduce vision loss

A drug that slows disability and reduces relapse rates in multiple sclerosis (MS) has been found to also reduce vision loss in patients with relapsing MS. Vision loss is one of the most common and debilitating symptoms of MS.

17 Apr 2007

Curcumin has anticancer effects

Curry powder is a mixture predominantly composed of turmeric root extract and other spices such as coriander and fenugreek.

14 Apr 2007

Richard Mayeux wins AAN Potamkin prize for Alzheimer's research

The American Academy of Neurology (AAN) is awarding the 2007 Potamkin Prize to Richard Mayeux, MD, MSc, Fellow of the AAN and co-director of the Taub Institute for Research on Alzheimer's and the Aging Brain, Columbia University Medical Center in New York, for his research related to Alzheimer's disease.

12 Apr 2007

Rep. Dave Weldon comments on stem therapy and type I diabetes

In yet another advance in adult stem cell therapy, the Journal of the American Medical Association (JAMA) today released a study in which 14 of 15 Juvenile Diabetes patients demonstrated significant improvement as a result of an adult stem cell treatment.

11 Apr 2007

Modified bone marrow cells help recovery in an animal model of multiple sclerosis

These findings will need to be repeated in further animal models before the implications for human disease are clear; however, they open up an avenue of further research.

10 Apr 2007

New role for sugars on proteins

In a ground-breaking study published in the top journal, Cell, Dr. James Dennis, senior investigator at the Samuel Lunenfeld Research Institute at Mount Sinai Hospital, has discovered a new role for sugars on proteins.

7 Apr 2007

Researchers show blood-brain barrier damage could affect multiple sclerosis severity

Immunology researchers at the Kimmel Cancer Center at Jefferson studying a multiple sclerosis (MS)-like disease in mice have shown that the amount of "damage" to the central nervous system's protective blood-brain barrier, in essence, opening it, almost always correlates to the severity of the disease.

7 Apr 2007